Medisys Universal Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-06-2024
- Paid Up Capital ₹ 1.97 Cr
as on 24-06-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 95.07%
(FY 2020)
- Profit 46.12%
(FY 2020)
- Ebitda 69.36%
(FY 2020)
- Net Worth -5.88%
(FY 2020)
- Total Assets 14.28%
(FY 2020)
About Medisys Universal
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kashi Singh, Ashok Srivastava, Mohan Ettyreddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397HR2015PTC056545
- Company No.
056545
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medisys Universal Private Limited offer?
Medisys Universal Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Nutritional Supplements, Weight Gain Nutrition.
Who are the key members and board of directors at Medisys Universal?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Srivastava  | Director | 02-Sep-2015 | Current |
| Kashi Singh | Director | 06-Jun-2017 | Current |
Mohan Ettyreddy  | Director | 08-Feb-2016 | Current |
| Rahul Sharma | Director | 17-Nov-2015 | Current |
| Sanjay Goel | Director | 02-Sep-2015 | Current |
Financial Performance of Medisys Universal.
Medisys Universal Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 95.07% increase. The company also saw a substantial improvement in profitability, with a 46.12% increase in profit. The company's net worth dipped by a decrease of 5.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisys Universal?
In 2020, Medisys Universal had a promoter holding of 48.52% and a public holding of 51.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medisys Biotech Private LimitedActive 19 years 17 daysAshok Srivastava, Mohan Ettyreddy and 1 more are mutual person
Primok Products Private LimitedActive 6 years 3 daysAshok Srivastava and Sanjay Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medisys Universal?
Unlock and access historical data on people associated with Medisys Universal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisys Universal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisys Universal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
